Implementation of a tool-based Capital Expenditure Process at Aventis

Feedback einreichen |

Weiterempfehlen |

Drucken |

Beobachten

Management Summary

The Aventis Group, one of the largest pharmaceutical corporations worldwide, was cre-ated in 1999 by a merger between Hoechst AG and Rhône-Poulenc S.A. The Group’s spectrum of products includes prescription drugs, vaccines and therapeutic proteins as well as animal health products. As part of the post-merger integration, Corporate Control-ling introduced a tool-supported reporting process for investment controlling (capital ex-penditure) of all national organizations and business units. The figures are collected by the project managers. There is no direct hierarchical relationship between the project managers and the central controlling department, so in the context of a multinational cor-poration, preparation of the accounts can be seen as a collaborative process. Flat consolidation increases data quality (measured in terms of the variance compared to the accounting figures) twelve-fold. Technical system support improves the information available to decision-makers through individualized evaluations and improves the protec-tion of sensitive data against unauthorized access. At the same time, 25% less time is re-quired for preparing the quarterly reports.

Referenz
Senger, E.: Case Study Aventis Pharma – Implementation of a tool-based Capital Expenditure Process, Institut für Wirtschaftsinformatik, Universität St. Gallen, St. Gallen, 2003, http://cases.iwi.unisg.ch

Erstellungsdatum der Fallstudie: Dec 1, 2003

Autor(en) der Fallstudie:

Enrico Senger

Lösungspartner:

The Information Management Group (IMG), St. Gallen

Harald Burghard, eCare IT-Project Manager

Betreiber der Lösung:

Aventis S.A.

Eric Marmonier

Corporate Controlling, Business Project Manager

Branche:

Chemical industry/Plastic goods
Pharma

Benutzername
Passwort

	Passwort vergessen?